Eventide Asset Management - Q2 2016 holdings

$1.63 Billion is the total value of Eventide Asset Management's 129 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 15.8% .

 Value Shares↓ Weighting
CELG  CELGENE CORP$69,278,000
-1.5%
702,4000.0%4.24%
+7.9%
LRCX BuyLAM RESEARCH CORP$56,160,000
+2.1%
668,100
+0.3%
3.44%
+11.8%
CCI BuyCROWN CASTLE INTL CORP NEW$53,347,000
+17.6%
525,950
+0.3%
3.26%
+28.8%
MIC BuyMACQUARIE INFRASTRUCTURE COR$52,849,000
+10.3%
713,700
+0.4%
3.23%
+20.8%
LOW SellLOWES COS INC$52,648,000
-4.8%
665,000
-9.0%
3.22%
+4.2%
ABBV BuyABBVIE INC$51,364,000
+8.8%
829,650
+0.4%
3.14%
+19.1%
FPRX SellFIVE PRIME THERAPEUTICS INC$44,873,000
-4.4%
1,085,200
-6.1%
2.75%
+4.7%
LEA  LEAR CORP$44,673,000
-8.5%
439,0000.0%2.73%
+0.3%
XPO  XPO LOGISTICS INC$42,497,000
-14.5%
1,618,3000.0%2.60%
-6.3%
MBBYF  MOBILEYE N V AMSTELVEEN$40,317,000
+23.7%
873,8000.0%2.47%
+35.5%
KAR SellKAR AUCTION SVCS INC$37,787,000
-17.7%
905,300
-24.8%
2.31%
-9.9%
STLD SellSTEEL DYNAMICS INC$36,517,000
+7.0%
1,490,500
-1.6%
2.24%
+17.3%
SPLK  SPLUNK INC$35,661,000
+10.7%
658,2000.0%2.18%
+21.2%
CYBR  CYBERARK SOFTWARE LTD$34,013,000
+14.0%
700,0000.0%2.08%
+24.8%
SGEN  SEATTLE GENETICS INC$33,763,000
+15.2%
835,5060.0%2.07%
+26.1%
PFPT  PROOFPOINT INC$31,097,000
+17.3%
492,9000.0%1.90%
+28.5%
ASML  ASML Holding NV$31,023,000
-1.2%
312,7000.0%1.90%
+8.2%
ATHN  ATHENAHEALTH INC$27,768,000
-0.6%
201,2000.0%1.70%
+8.9%
PANW SellPALO ALTO NETWORKS INC$27,594,000
-53.5%
225,000
-38.1%
1.69%
-49.0%
FSLR BuyFIRST SOLAR INC$27,391,000
+300.0%
565,000
+465.0%
1.68%
+337.6%
MGA BuyMAGNA INTL INC$25,864,000
-17.5%
737,500
+1.1%
1.58%
-9.6%
IPHI  INPHI CORP$25,595,000
-3.9%
799,1000.0%1.57%
+5.2%
WAB  WABTEC CORP$24,581,000
-11.4%
350,0000.0%1.50%
-3.0%
WBC  WABCO HLDGS INC$23,405,000
-14.4%
255,6000.0%1.43%
-6.2%
BLUE  BLUEBIRD BIO INC$23,355,000
+1.9%
539,5000.0%1.43%
+11.6%
COLL BuyCOLLEGIUM PHARMACEUTICAL INC$23,111,000
-31.7%
1,950,276
+4.6%
1.41%
-25.3%
CPN SellCALPINE CORP$22,568,000
-19.3%
1,530,000
-17.0%
1.38%
-11.6%
IDTI  INTEGRATED DEVICE TECHNOLOGY$21,070,000
-1.5%
1,046,7000.0%1.29%
+7.9%
SYNA  SYNAPTICS INC$20,989,000
-32.6%
390,5000.0%1.28%
-26.2%
NEP BuyNEXTERA ENERGY PARTNERS LP$20,139,000
+11.8%
662,900
+0.0%
1.23%
+22.3%
PEGI BuyPATTERN ENERGY GROUP INCcl a$19,766,000
+21.7%
860,500
+1.1%
1.21%
+33.4%
MGNX  MACROGENICS INC$19,589,000
+43.9%
725,8000.0%1.20%
+57.8%
CRUS  CIRRUS LOGIC INC$19,395,000
+6.5%
500,0000.0%1.19%
+16.7%
ARW NewARROW ELECTRS INC$18,261,000295,000
+100.0%
1.12%
CAFD Buy8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt$18,115,000
+9.1%
1,146,500
+1.5%
1.11%
+19.5%
LOXO  LOXO ONCOLOGY INC$17,153,000
-15.2%
740,0000.0%1.05%
-7.1%
AY NewATLANTICA YIELD PLC$16,990,000914,400
+100.0%
1.04%
CBI  CHICAGO BRIDGE & IRON CO N V$16,913,000
-5.4%
488,4000.0%1.04%
+3.6%
STKL  SUNOPTA INC$16,059,000
-6.0%
3,832,6000.0%0.98%
+2.9%
NVAX  NOVAVAX INC$15,846,000
+40.9%
2,179,7000.0%0.97%
+54.5%
EXR SellEXTRA SPACE STORAGE INC$15,732,000
-32.7%
170,000
-32.0%
0.96%
-26.3%
SPWR  SUNPOWER CORP$15,490,000
-30.7%
1,000,0000.0%0.95%
-24.0%
XLRN BuyACCELERON PHARMA INC$14,574,000
+30.4%
428,900
+1.3%
0.89%
+42.9%
LLTC  LINEAR TECHNOLOGY CORP$13,615,000
+4.4%
292,6000.0%0.83%
+14.3%
DATA SellTABLEAU SOFTWARE INCcl a$13,208,000
-22.7%
270,000
-27.5%
0.81%
-15.4%
BWA SellBORGWARNER INC$12,989,000
-31.2%
440,000
-10.6%
0.80%
-24.7%
AGIO  AGIOS PHARMACEUTICALS INC$12,602,000
+3.2%
300,8000.0%0.77%
+13.0%
ORA BuyORMAT TECHNOLOGIES INC$12,295,000
+6.3%
280,959
+0.2%
0.75%
+16.4%
SUPN  SUPERNUS PHARMACEUTICALS INC$11,713,000
+33.6%
575,0000.0%0.72%
+46.3%
VCYT  VERACYTE INC$11,328,000
-6.8%
2,252,0000.0%0.69%
+1.9%
HASI BuyHANNON ARMSTRONG SUST INFR C$10,966,000
+56.3%
507,667
+39.1%
0.67%
+71.2%
ACAD  ACADIA PHARMACEUTICALS INC$10,864,000
+16.1%
334,7000.0%0.66%
+27.2%
CSIQ  CANADIAN SOLAR INC$9,072,000
-21.6%
600,0000.0%0.56%
-14.1%
MDVN SellMEDIVATION INC$9,045,000
-59.4%
150,000
-69.0%
0.55%
-55.5%
TSLA SellTESLA MTRS INC$8,491,000
-66.5%
40,000
-63.7%
0.52%
-63.3%
AYR  AIRCASTLE LTD$8,383,000
-12.1%
428,6000.0%0.51%
-3.8%
DBVT  DBV TECHNOLOGIES S Asponsored adr$8,142,000
+0.2%
249,6000.0%0.50%
+9.7%
WVE NewWAVE LIFE SCIENCES LTD$7,862,000380,000
+100.0%
0.48%
ONCE  SPARK THERAPEUTICS INC$7,670,000
+73.3%
150,0000.0%0.47%
+89.9%
TSRO SellTESARO INC$7,565,000
-4.5%
90,000
-50.0%
0.46%
+4.5%
KITE  KITE PHARMA INC$7,430,000
+8.9%
148,6000.0%0.46%
+19.4%
 ESSA PHARMA INC$7,370,000
-5.8%
2,719,4100.0%0.45%
+3.2%
UFS SellDOMTAR CORP$7,002,000
-56.8%
200,000
-50.0%
0.43%
-52.7%
CSLT  CASTLIGHT HEALTH INCcl b$6,766,000
+18.9%
1,708,6000.0%0.41%
+30.2%
GWPH  GW PHARMACEUTICALS PLCads$6,730,000
+26.9%
73,5000.0%0.41%
+39.2%
XNCR  XENCOR INC$6,533,000
+41.5%
344,0000.0%0.40%
+55.0%
CERN  CERNER CORP$6,341,000
+10.7%
108,2000.0%0.39%
+21.2%
BMRN  BIOMARIN PHARMACEUTICAL INC$5,835,000
-5.7%
75,0000.0%0.36%
+3.2%
STML  STEMLINE THERAPEUTICS INC$5,764,000
+45.3%
851,4000.0%0.35%
+59.0%
NBIX  NEUROCRINE BIOSCIENCES INC$5,681,000
+14.9%
125,0000.0%0.35%
+26.1%
BPMC BuyBLUEPRINT MEDICINES CORP$5,366,000
+20.6%
265,000
+7.5%
0.33%
+31.7%
MCRB  SERES THERAPEUTICS INC$5,177,000
+9.4%
178,2000.0%0.32%
+20.1%
SAGE  SAGE THERAPEUTICS INC$5,122,000
-6.0%
170,0000.0%0.31%
+2.6%
ALNY  ALNYLAM PHARMACEUTICALS INC$4,994,000
-11.6%
90,0000.0%0.31%
-3.2%
RARE  ULTRAGENYX PHARMACEUTICAL IN$4,275,000
-22.7%
87,4000.0%0.26%
-15.2%
PRTA  PROTHENA CORP PLC$4,195,000
-15.1%
120,0000.0%0.26%
-6.9%
AGTC  APPLIED GENETIC TECHNOL CORP$3,944,000
+1.1%
279,1000.0%0.24%
+10.6%
DVAX  DYNAVAX TECHNOLOGIES CORP$3,645,000
-24.2%
250,0000.0%0.22%
-17.1%
JUNO  JUNO THERAPEUTICS INC$3,460,000
+0.9%
90,0000.0%0.21%
+10.4%
VYGR  VOYAGER THERAPEUTICS INC$3,297,000
+25.9%
300,0000.0%0.20%
+38.4%
TGTX  TG THERAPEUTICS INC$3,258,000
-28.9%
537,6000.0%0.20%
-22.3%
INCY  INCYTE CORP$3,199,000
+10.3%
40,0000.0%0.20%
+21.0%
CEMP  CEMPRA INC$3,049,000
-5.9%
184,9000.0%0.19%
+3.3%
RGEN  REPLIGEN CORP$3,010,000
+2.0%
110,0000.0%0.18%
+11.5%
VRTX  VERTEX PHARMACEUTICALS INC$2,976,000
+8.2%
34,6000.0%0.18%
+18.2%
GLPG  GALAPAGOS NVspon adr$2,884,000
+32.6%
52,0000.0%0.18%
+44.3%
NTUS  NATUS MEDICAL INC DEL$2,835,000
-1.6%
75,0000.0%0.17%
+7.5%
EPZM  EPIZYME INC$2,816,000
-15.5%
275,0000.0%0.17%
-7.5%
CDTX  CIDARA THERAPEUTICS INC$2,722,000
-18.8%
264,0000.0%0.17%
-10.7%
GBT  GLOBAL BLOOD THERAPEUTICS IN$2,737,000
+4.6%
165,0000.0%0.17%
+14.4%
SYRS NewSYROS PHARMACEUTICALS INC$2,723,000150,000
+100.0%
0.17%
TTPH NewTETRAPHASE PHARMACEUTICALS I$2,580,000600,000
+100.0%
0.16%
ATRC  ATRICURE INC$2,543,000
-16.0%
180,0000.0%0.16%
-7.7%
CHRS  COHERUS BIOSCIENCES INC$2,449,000
-20.4%
145,0000.0%0.15%
-12.8%
PTI  PROTEOSTASIS THERAPEUTICS IN$2,426,000
+25.8%
200,0000.0%0.15%
+37.0%
OMED  ONCOMED PHARMACEUTICALS INC$2,339,000
+21.8%
190,0000.0%0.14%
+33.6%
TCON  TRACON PHARMACEUTICALS INC$2,268,000
-37.3%
517,7000.0%0.14%
-31.2%
TNDM BuyTANDEM DIABETES CARE INC$2,074,000
+51.8%
275,000
+75.4%
0.13%
+67.1%
ARAY NewACCURAY INC$1,589,000306,200
+100.0%
0.10%
CTMX  CYTOMX THERAPEUTICS INC$1,532,000
-20.8%
150,0000.0%0.09%
-13.0%
IMDZ  IMMUNE DESIGN CORP$1,469,000
-37.2%
180,0000.0%0.09%
-31.3%
ZSAN  ZOSANO PHARMA CORP$1,173,000
-42.6%
888,3000.0%0.07%
-36.8%
DRNA  DICERNA PHARMACEUTICALS INC$1,131,000
-44.0%
377,0000.0%0.07%
-38.9%
SEP BuySPECTRA ENERGY PARTNERS LP$811,000
+75.5%
17,200
+79.0%
0.05%
+92.3%
HTGC BuyHERCULES CAPITAL INC$795,000
+59.0%
64,000
+53.8%
0.05%
+75.0%
JCI BuyJOHNSON CTLS INC$673,000
+56.9%
15,200
+38.2%
0.04%
+70.8%
TSM BuyTAIWAN SEMICONDUCTOR MFG LTDsponsored adr$677,000
+61.6%
25,800
+61.2%
0.04%
+78.3%
BEP BuyBROOKFIELD RENEWABLE PARTNERpartnership unit$596,000
+113.6%
20,000
+115.1%
0.04%
+125.0%
BDN BuyBRANDYWINE RLTY TRsh ben int new$580,000
+50.3%
34,500
+25.5%
0.04%
+59.1%
CPPL BuyCOLUMBIA PIPELINE PARTNERS L$533,000
+76.5%
35,500
+71.6%
0.03%
+94.1%
NYLD BuyNRG YIELD INCcl c$514,000
+80.4%
33,000
+65.0%
0.03%
+93.8%
ETN BuyEATON CORP PLC$346,000
+31.6%
5,800
+38.1%
0.02%
+40.0%
BBN SellBLACKROCK TAX MUNICPAL BD TR$328,000
-1.2%
13,450
-6.9%
0.02%
+5.3%
ABB BuyABB LTDsponsored adr$307,000
+26.3%
15,500
+24.0%
0.02%
+35.7%
LPT BuyLIBERTY PPTY TRsh ben int$290,000
+57.6%
7,300
+32.7%
0.02%
+80.0%
WELL  WELLTOWER INC$274,000
+9.6%
3,6000.0%0.02%
+21.4%
ERIC BuyERICSSONadr b sek 10$276,000
+34.0%
36,000
+75.6%
0.02%
+41.7%
NSC BuyNORFOLK SOUTHERN CORP$255,000
+33.5%
3,000
+30.4%
0.02%
+45.5%
APU BuyAMERIGAS PARTNERS L Punit l p int$210,000
+92.7%
4,500
+80.0%
0.01%
+116.7%
BG BuyBUNGE LIMITED$201,000
+60.8%
3,400
+54.5%
0.01%
+71.4%
LXP BuyLEXINGTON REALTY TRUST$147,000
+34.9%
14,500
+14.2%
0.01%
+50.0%
VTR  VENTAS INC$124,000
+15.9%
1,7000.0%0.01%
+33.3%
BAB SellPOWERSHARES ETF TR IIbuild amer etf$133,000
-15.3%
4,211
-19.2%
0.01%
-11.1%
WBK BuyWESTPAC BKG CORPsponsored adr$121,000
+86.2%
5,500
+96.4%
0.01%
+75.0%
 TESLA MTRS INCnote 0.250% 3/0$89,000
-2.2%
100,0000.0%0.01%0.0%
NATI  NATIONAL INSTRS CORP$77,000
-8.3%
2,8000.0%0.01%0.0%
TERP  TERRAFORM PWR INC$51,000
+27.5%
4,6500.0%0.00%
+50.0%
GLBL  TERRAFORM GLOBAL INCcl a$28,000
+33.3%
8,7000.0%0.00%
+100.0%
RMR  RMR GROUP INCcl a$1,0000.0%370.0%0.00%
SE ExitSPECTRA ENERGY CORP$0-1,000
-100.0%
-0.00%
DLR ExitDIGITAL RLTY TR INC$0-650
-100.0%
-0.00%
BIP ExitBROOKFIELD INFRAST PARTNERSlp int unit$0-2,000
-100.0%
-0.01%
SYK ExitSTRYKER CORP$0-1,000
-100.0%
-0.01%
GOV ExitGOVERNMENT PPTYS INCOME TR$0-7,000
-100.0%
-0.01%
INFI ExitINFINITY PHARMACEUTICALS INC$0-246,700
-100.0%
-0.07%
ExitACCURAY INC$0-306,200
-100.0%
-0.10%
QURE ExitUNIQURE NV$0-174,900
-100.0%
-0.12%
INSM ExitINSMED INC$0-210,000
-100.0%
-0.15%
SRPT ExitSAREPTA THERAPEUTICS INC$0-332,300
-100.0%
-0.36%
PTLA ExitPORTOLA PHARMACEUTICALS INC$0-393,000
-100.0%
-0.45%
LGND ExitLIGAND PHARMACEUTICALS INC$0-80,000
-100.0%
-0.48%
ABY ExitABENGOA YIELD PLC$0-905,000
-100.0%
-0.90%
IMPV ExitIMPERVA INC$0-321,900
-100.0%
-0.91%
QLIK ExitQLIK TECHNOLOGIES INC$0-1,005,800
-100.0%
-1.62%
RHT ExitRED HAT INC$0-621,600
-100.0%
-2.59%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-08-15
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC40Q3 20233.2%
PALO ALTO NETWORKS INC40Q3 20233.6%
ASML HOLDINGS NV40Q3 20231.9%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
REPLIGEN CORP40Q3 20230.5%
VERACYTE INC38Q3 20231.5%
LAM RESEARCH CORP35Q3 20233.4%
XPO LOGISTICS INC34Q1 20233.8%
COLLEGIUM PHARMACEUTICAL INC34Q3 20232.6%
MAGNA INTL INC33Q4 20212.5%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q2 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cogent Biosciences, Inc.February 14, 20232,589,7783.7%
ESSA Pharma Inc.Sold outFebruary 14, 202300.0%
Freeline Therapeutics Holdings plcFebruary 14, 20235,920,7659.1%
KnowBe4, Inc.Sold outFebruary 14, 202300.0%
Praxis Precision Medicines, Inc.February 14, 20233,518,0627.5%
Prometheus Biosciences, Inc.February 14, 20231,032,9382.2%
SUTRO BIOPHARMA, INC.Sold outFebruary 14, 202300.0%
Vital Farms, Inc.Sold outFebruary 14, 202300.0%
Zymeworks Inc.Sold outFebruary 14, 202300.0%
Entasis Therapeutics Holdings Inc.February 14, 2022590,6021.2%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings